Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TRANSFERASE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tamanoi, F; Gau, CL; Jiang, C; Edamatsu, H; Kato-Stankiewicz, J
      Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cells

      CELLULAR AND MOLECULAR LIFE SCIENCES
    2. Scozzafava, A; Mastrolorenzo, A; Supuran, CT
      Agents that target cysteine residues of biomolecules and their therapeuticpotential

      EXPERT OPINION ON THERAPEUTIC PATENTS
    3. Qin, XZ
      Tandem mass spectrum of a farnesyl transferase inhibitor - gas-phase rearrangements involving imidazole

      JOURNAL OF MASS SPECTROMETRY
    4. Punt, CJA; van Maanen, L; Bol, CJJG; Seifert, WF; Wagener, DJT
      Phase I and pharmacokinetic study of the ovally administered farnesyl transferase inhibitor R115777 in patients with advanced solid tumors

      ANTI-CANCER DRUGS
    5. Germano, D; Pacilio, C; Cancemi, M; Cicatiello, L; Altucci, L; Petrizzi, VB; Sperandio, C; Salzano, S; Michalides, RJAM; Taya, Y; Bresciani, F; Weisz, A
      Inhibition of human breast cancer cell growth by blockade of the mevalonate-protein prenylation pathway is not prevented by overexpression of cyclin D1

      BREAST CANCER RESEARCH AND TREATMENT
    6. Xu, GP; Pan, JX; Martin, C; Yeung, SCJ
      Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    7. Hu, YD; Floss, HG
      New type II manumycins produced by Streptomyces nodosus ssp asukaensis andtheir biosynthesis

      JOURNAL OF ANTIBIOTICS
    8. Meuwissen, R; Jonkers, J; Berns, A
      Mouse models for sporadic cancer

      EXPERIMENTAL CELL RESEARCH
    9. Work, LM; McPhaden, AR; Pyne, NJ; Pyne, S; Wadsworth, RM; Wainwright, CL
      Short-term local delivery of an inhibitor of ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty

      CIRCULATION
    10. Cohen-Jonathan, E; Evans, SM; Koch, CJ; Muschel, RJ; McKenna, WG; Wu, JM; Bernhard, EJ
      The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras

      CANCER RESEARCH
    11. Chiba, M; Tang, CY; Neway, WE; Williams, TM; Desolms, SJ; Dinsmore, CJ; Wai, JS; Lin, JH
      P450 interaction with farnesyl-protein transferase inhibitors - Metabolic stability, inhibitory potency, and P450 binding spectra in human liver microsomes

      BIOCHEMICAL PHARMACOLOGY
    12. Glass, TL; Liu, TJ; Yung, WKA
      Inhibition of cell growth in human glioblastoma cell lines by farnesyltransferase inhibitor SCH66336

      NEURO-ONCOLOGY
    13. Vilella, D; Sanchez, M; Platas, G; Salazar, O; Genilloud, O; Royo, I; Cascales, C; Martin, I; Diez, T; Silverman, KC; Lingham, RB; Singh, SB; Jayasuriya, H; Pelaez, F
      Inhibitors of farnesylation of Ras from a microbial natural products screening program

      JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
    14. Kath, JC
      Patent focus: inhibitors of tumour cell growth

      EXPERT OPINION ON THERAPEUTIC PATENTS
    15. Sebti, SM; Hamilton, AD
      Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies

      ONCOGENE
    16. Shi, B; Yaremko, B; Hajian, G; Terracina, G; Bishop, WR; Liu, M; Nielsen, LL
      The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    17. Saijo, N; Tamura, T; Nishio, K
      Problems in the development of target-based drugs

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    18. Di Paolo, A; Danesi, R; Nardini, D; Bocci, G; Innocenti, F; Fogli, S; Barachini, S; Marchetti, A; Bevilacqua, G; Del Tacca, M
      Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells

      BRITISH JOURNAL OF CANCER
    19. Kunze, T; Heps, S
      Phosphono analogs of glutathione: Inhibition of glutathione transferases, metabolic stability, and uptake by cancer cells

      BIOCHEMICAL PHARMACOLOGY
    20. Feldkamp, MM; Lau, N; Guha, A
      Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects

      ONCOGENE
    21. Liu, M; Bryant, MS; Chen, JP; Lee, SN; Yaremko, B; Li, ZJ; Dell, J; Lipari, P; Malkowski, M; Prioli, N; Rossman, RR; Korfmacher, WA; Nomeir, AA; Lin, CC; Mallams, AK; Doll, RJ; Catino, JJ; Girijavallabhan, VM; Kirschmeier, P; Bishop, WR
      Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    22. Charvat, S; Duchesne, M; Parvaz, P; Chignol, MC; Schmitt, D; Serres, M
      The up-regulation of vascular endothelial growth factor in mutated Ha-ras HaCaT cell lines is reduced by a farnesyl transferase inhibitor

      ANTICANCER RESEARCH
    23. Pollack, IF; Bredel, M; Erff, M; Hamilton, AD; Sebti, SM
      Inhibition of Ras and related guanosine triphosphate-dependent proteins asa therapeutic strategy for blocking malignant glioma growth: II - Preclinical studies in a nude mouse model

      NEUROSURGERY
    24. Feldkamp, MM; Angelov, L; Guha, A
      Neurofibromatosis type 1 peripheral nerve tumors: Aberrant activation of the Ras pathway

      SURGICAL NEUROLOGY
    25. Wang, W; Macaulay, RJB
      Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A

      INTERNATIONAL JOURNAL OF CANCER
    26. Du, W; Prendergast, GC
      Geranylgeranylaled RhoB mediates suppression of human tumor cell growth byfarnesyltransferase inhibitors

      CANCER RESEARCH
    27. Mahgoub, N; Taylor, BR; Gratiot, M; Kohl, NE; Gibbs, JB; Jacks, T; Shannon, KM
      In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells

      BLOOD
    28. KOHGO Y; KATO J
      SYMPOSIUM ON APOPTOSIS AND MEDICAL DISEASES - 2 - ROLE OF APOPTOSIS ON MORPHOGENESIS AND THERAPY IN MALIGNANCY

      Internal medicine
    29. URA H; OBARA T; SHUDO R; ITOH A; TANNO S; FUJII T; NISHINO N; KOHGO Y
      SELECTIVE CYTOTOXICITY OF FARNESYLAMINE TO PANCREATIC-CARCINOMA CELLSAND KI-RAS-TRANSFORMED FIBROBLASTS

      Molecular carcinogenesis
    30. LEEKWON W; PARK D; BERNIER M
      INVOLVEMENT OF THE RAS EXTRACELLULAR SIGNAL-REGULATED KINASE SIGNALING PATHWAY IN THE REGULATION OF ERCC-1 MESSENGER-RNA LEVELS BY INSULIN

      Biochemical journal
    31. KAINUMA O; ASANO T; HASEGAWA M; KENMOCHI T; NAKAGOHRI T; TOKORO Y; ISONO K
      INHIBITION OF GROWTH AND INVASIVE ACTIVITY OF HUMAN PANCREATIC-CANCERCELLS BY A FARNESYLTRANSFERASE INHIBITOR, MANUMYCIN

      Pancreas
    32. YANG WL; DELVILLAR K; URANO J; MITSUZAWA H; TAMANOI F
      ADVANCES IN THE DEVELOPMENT OF FARNESYLTRANSFERASE INHIBITORS - SUBSTRATE RECOGNITION BY PROTEIN FARNESYLTRANSFERASE

      Journal of cellular biochemistry
    33. FELDKAMP MM; LAU N; GUHA A
      SIGNAL-TRANSDUCTION PATHWAYS AND THEIR RELEVANCE IN HUMAN ASTROCYTOMAS

      Journal of neuro-oncology
    34. NAGASE T; KAWATA S; TAMURA S; MATSUDA Y; INUI Y; YAMASAKI E; ISHIGURO H; ITO T; MIYAGAWA J; MITSUI H; YAMAMOTO K; KINOSHITA M; MATSUZAWA Y
      MANUMYCIN AND GLIOTOXIN DERIVATIVE KT7595 BLOCK RAS FARNESYLATION ANDCELL-GROWTH BUT DO NOT DISTURB LAMIN FARNESYLATION AND LOCALIZATION IN HUMAN TUMOR-CELLS

      British Journal of Cancer
    35. ITO T; KAWATA S; TAMURA S; IGURA T; NAGASE T; MIYAGAWA J; YAMAZAKI E; ISHIGURO H; MATSUZAWA Y
      SUPPRESSION OF HUMAN PANCREATIC-CANCER GROWTH IN BALB C NUDE-MICE BY MANUMYCIN, A FARNESYL-PROTEIN TRANSFERASE INHIBITOR/

      Japanese journal of cancer research
    36. DAVIS TL; ROZNOSKI M; BURNS RS
      ACUTE EFFECTS OF COMT INHIBITION ON L-DOPA PHARMACOKINETICS IN PATIENTS TREATED WITH CARBIDOPA AND SELEGILINE

      Clinical neuropharmacology
    37. KASHIWAGI A
      RATIONALE AND HURDLES OF INHIBITORS OF HEPATIC GLUCONEOGENESIS IN TREATMENT OF DIABETES-MELLITUS

      Diabetes research and clinical practice
    38. PAULSEN H; SPRINGER M; RECK F; BROCKHAUSEN I; SCHACHTER H
      SYNTHESIS OF MODIFIED TETRASACCHARIDES AS ACCEPTOR-INHIBITOR ANALOGS OF N-ACETYLGLUCOSAMINYLTRANSFERASE-II

      Carbohydrate research
    39. PAUWELS T; DETHY S; GOLDMAN S; MONCLUS M; LUXEN A
      EFFECT OF CATECHOL-O-METHYL TRANSFERASE INHIBITION ON PERIPHERAL AND CENTRAL METABOLISM OF 6-[F-18]FLUORO-L-DOPA

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 21:00:23